Sara Manglaviti - Dissemin

Language
Login

All papers authored by Sara Manglaviti

This paper was not found in any repository, but could be made available legally by the author.

2024 Rita Leporati

ORCID

, Daniela Miliziano, Teresa Beninato

ORCID

ORCID

, Sara Manglaviti

ORCID

, Marta Brambilla

ORCID

, Mario Occhipinti

ORCID

, Arsela Prelaj, Claudia Proto, Giuseppe Lo Russo

Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs

Upload

This paper was not found in any repository, but could be made available legally by the author.

2023 Luca Cantini, Francesco Paoloni, Federica Pecci, Francesco Spagnolo, Carlo Genova, Enrica Teresa Tanda, Sophie Aerts, Sara Elena Rebuzzi

ORCID

, Giuseppe Fornarini, Federica Zoratto, Sara Fancelli, Alessio Lupi, Carminia Maria Della Corte, Alessandro Parisi

ORCID

, Chiara Bennati and 36 other authors

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Gabriele Antonarelli

ORCID

ORCID

, Paolo Andrea Zucali, Matteo Perrino, Sara Manglaviti

ORCID

, Giuseppe Lo Russo, Gianluca Maria Varano

ORCID

, Piermario Salvini, Giuseppe Curigliano

ORCID

, Chiara Catania, Fabio Conforti, Tommaso De Pas

ORCID

Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group

Upload

This paper was not found in any repository, but could be made available legally by the author.

Federica Giugliano

ORCID

, Paolo A. Zucali

ORCID

, Giulia Galli, Zelmira Ballatore, Chiara Corti

ORCID

, Pamela T. Aliaga

ORCID

, Jacopo Uliano, Grazia Vivanet, Giuseppe Curigliano

ORCID

, Fabio Conforti, Paola Queirolo

ORCID

, Rossana Berardi, Sara Manglaviti

ORCID

, Giulia Apollonio, Matteo Perrino and 4 other authors

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis

Upload

This paper is made freely available by the publisher.

Arsela Prelaj

ORCID

ORCID

, Alessandro Robuschi, Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Giulia Galli

ORCID

, Alessandro De Toma, Marta Brambilla, Mario Occhipinti, Sara Manglaviti

ORCID

, Teresa Beninato, Achille Bottiglieri

ORCID

, Giacomo Massa, Emma Zattarin and 9 other authors

Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Sara Manglaviti

ORCID

, Marta Brambilla, Diego Signorelli, Roberto Ferrara, Giuseppe Lo Russo, Claudia Proto, Giulia Galli, Alessandro De Toma, Mario Occhipinti, Giuseppe Viscardi, Teresa Beninato, Emma Zattarin, Marta Bini, Riccardo Lobefaro, Giacomo Massa

ORCID

and 10 other authors

Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology

Upload

This paper is made freely available by the publisher.

2021 Mario Occhipinti

ORCID

, Marta Brambilla, Giulia Galli, Sara Manglaviti

ORCID

, Maristella Giammaruco, Arsela Prelaj

ORCID

, Roberto Ferrara, Alessandro De Toma, Claudia Proto, Teresa Beninato, Emma Zattarin, Giuseppe Lo Russo, Alain Jonathan Gelibter, Maurizio Simmaco, Robert Preissner and 3 other authors

Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Arsela Prelaj, Achille Bottiglieri

ORCID

, Claudia Proto, Giuseppe Lo Russo, Diego Signorelli, Roberto Ferrara, Giulia Galli, Alessandro De Toma, Giuseppe Viscardi, Marta Brambilla, Riccardo Lobefaro

ORCID

, Federico Nichetti, Sara Manglaviti

ORCID

, Mario Occhipinti, Alice Labianca and 7 other authors

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program

Upload

This paper is made freely available by the publisher.

2020 Marta Brambilla

ORCID

, Giuseppe Lo Russo, Roberto Ferrara

ORCID

, Sara Manglaviti

ORCID

, Marina Chiara Garassino, Mario Occhipinti

ORCID

Is hyperprogressive disease a specific phenomenom of immunotherapy?

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Daniele Rossini, Marco Maria Germani, Filippo Pagani, Antonio Pellino

ORCID

, Emanuela Dell’Aquila, Maria Bensi

ORCID

, Nicole Liscia, Roberto Moretto, Alessandra Boccaccino, Michele Prisciandaro, Sara Manglaviti

ORCID

, Marta Schirripa, Raffaella Vivolo, Mario Scartozzi, Daniele Santini and 5 other authors

Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis

Upload

This paper is made freely available by the publisher.

Giovanni Fucà, Chiara Fabbroni, Rosanna Mancari, Sara Manglaviti

ORCID

, Giorgio Bogani, Elena Fumagalli, Rossella Bertulli, Carlo Morosi, Paola Collini, Francesco Raspagliesi, Nicoletta Colombo, Paolo G. Casali, Roberta Sanfilippo

Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers

Download from link.springer.com

This paper is made freely available by the publisher.

Monica Niger, Michele Prisciandaro, Maria Antista, Melissa Anna Teresa Monica, Laura Cattaneo, Natalie Prinzi, Sara Manglaviti

ORCID

, Federico Nichetti, Marta Brambilla, Martina Torchio, Francesca Corti, Sara Pusceddu, Jorgelina Coppa, Vincenzo Mazzaferro, Filippo de Braud and 1 other authors

One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches

Download from doi.org

This paper is made freely available by the publisher.

Francesca Corti

ORCID

, Marta Brambilla

ORCID

, Sara Manglaviti

ORCID

, Laura Di Vico, Maria Neve Pisanu, Claudia Facchinetti, Katia Fiorella Dotti, Rodolfo Lanocita, Alfonso Marchianò, Filippo de Braud, Laura Anna Maria Ferrari

Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis

Download from journals.sagepub.com

This paper is made freely available by the publisher.

Claudio Vernieri, Francesca Corti, Federico Nichetti, Francesca Ligorio, Sara Manglaviti

ORCID

, Emma Zattarin, Carmen G. Rea, Giuseppe Capri, Giulia V. Bianchi, Filippo de Braud

Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications

Download from link.springer.com

This paper is made freely available by the publisher.

Claudio Vernieri

ORCID

, Michele Prisciandaro

ORCID

, Federico Nichetti

ORCID

, Riccardo Lobefaro, Giorgia Peverelli, Francesca Ligorio, Emma Zattarin, Maria Silvia Cona, Pierangela Sepe, Francesca Corti, Sara Manglaviti

ORCID

, Marta Brambilla, Barbara Re, Antonino Belfiore

ORCID

, Giancarlo Pruneri and 6 other authors

Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer

Download from doi.org

Missing publications? Search for publications with a matching author name.